Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

AAIC 2023

16–20 July 2023 | Amsterdam, Netherlands

AAIC 2023

16–20 July 2023 | Amsterdam, Netherlands
Retinal protein aggregates as biomarkers in Alzheimer’s and Parkinson’s disease. 2:06
Retinal protein aggregates as biomarkers in Alzheimer’s and Parkinson’s disease.
Frederique Hart de Ruyter • 18 Jul 2023
Using 7-Tesla MRI to study cerebral impacts of COVID-19 infection 2:36
Using 7-Tesla MRI to study cerebral impacts of COVID-19 infection
Tamer Ibrahim • 24 Jul 2023
APOE-induced lipid changes and Alzheimer’s disease pathogenesis 1:08
APOE-induced lipid changes and Alzheimer’s disease pathogenesis
Femke Feringa • 19 Jul 2023
PET imaging of reactive astrogliosis in Alzheimer’s disease 1:44
PET imaging of reactive astrogliosis in Alzheimer’s disease
Mona-Lisa Malarte • 18 Jul 2023
Using neuropsychiatric symptoms as clinical markers for dementia diagnosis 1:05
Using neuropsychiatric symptoms as clinical markers for dementia diagnosis
Byron Creese • 17 Jul 2023
Prioritizing diversity in Alzheimer’s disease biomarker studies 1:27
Prioritizing diversity in Alzheimer’s disease biomarker studies
Suzanne Schindler • 18 Jul 2023
Late-life major depression impacts plasma Aβ dynamics 1:19
Late-life major depression impacts plasma Aβ dynamics
Jaime Ramos Cejudo • 17 Jul 2023
Use of machine learning to identify signs of cognitive decline 2:06
Use of machine learning to identify signs of cognitive decline
Ryan Falck • 18 Jul 2023
Multi-PET tracers reveal the complex nature of 4R tauopathies 1:16
Multi-PET tracers reveal the complex nature of 4R tauopathies
Mona-Lisa Malarte • 18 Jul 2023
Biomarkers in DLB trials 1:57
Biomarkers in DLB trials
Carla Abdelnour • 17 Jul 2023
Natural killer cell integrity within Alzheimer’s disease 1:24
Natural killer cell integrity within Alzheimer’s disease
Paul Y Song • 18 Jul 2023
Immune activation states in Alzheimer’s disease mouse models 2:28
Immune activation states in Alzheimer’s disease mouse models
Todd E. Golde • 18 Jul 2023
AI with advanced retinal imaging techniques to detect neurodegenerative disease risk markers 4:17
AI with advanced retinal imaging techniques to detect neurodegenerative disease risk markers
Frederique Hart de Ruyter • 18 Jul 2023
Measuring cognitive impairment in early Alzheimer’s disease 1:16
Measuring cognitive impairment in early Alzheimer’s disease
Suzanne Hendrix • 19 Jul 2023
Gut microbiome composition and cognitive function in middle-aged adults 4:34
Gut microbiome composition and cognitive function in middle-aged adults
Jazmyn A Muhammad • 28 Jul 2023
Treating patients with hearing loss and cognitive impairment 2:38
Treating patients with hearing loss and cognitive impairment
Dona Jayakody • 17 Jul 2023
The content of VJDementia is intended for healthcare professionals